LCN2 and cholangiocarcinoma: For cholangiocarcinoma, vitamin D analogues can arrest the cell cycle at G0/G1 phase and inhibit human neutrophil gelatinase-associated lipocalin (NGAL) to repress growth of cholangiocarcinoma cells in vitro and in vivo [30, 31].